Study details
Enrolling now
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
National Cancer Institute (NCI)
NCT IDNCT05616650ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
42
Study length
about 5.1 years
Ages
18–120
Sex
Male only
Locations
1 site in MD
What this study is about
This trial is testing focal therapy with SBRT to see how people with early prostate cancer respond. Participants will receive radiation treatment using small gold seeds and follow-up scans and blood tests for two years.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Stereotactic Body Radiation Therapy
- 2.Take 18F-DCFPyL
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
piflufolastat (18F)
Endpoints
Primary: Pathologic complete response rate
Secondary: Longitudinal quality of life (QoL), Toxicity profile
Procedures
radiation
Body systems
Oncology